S R Schwid, J L Trotter. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Adjuvants, Immunologic/administration & dosageAdjuvants, Immunologic/adverse effectsAdultAgedDisability EvaluationDose-Response Relationship, DrugDouble-Blind MethodFemaleHumansHydroxyquinolines/administration & dosageHydroxyquinolines/adverse effectsMaleMiddle AgedMultiple Sclerosis, Chronic Progressive/diagnosisMultiple Sclerosis, Chronic Progressive/drug therapyMultiple Sclerosis, Relapsing-Remitting/drug therapyTreatment Failure
Substances: See more » Adjuvants, ImmunologicHydroxyquinolinesroquinimex
Year: 2000 PMID: 10802772 DOI: 10.1212/wnl.54.9.1716
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910